On September 9, 2021 Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, reported that James Oliviero, President and Chief Executive Officer, will participate in two upcoming investor conferences (Press release, Checkmate Pharmaceuticals, SEP 9, 2021, View Source [SID1234587541]). Details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference:
Date: Monday, September 13, 2021
Time: On demand as of 7 a.m. ET
Webcast: Register Here
A webcast of the company’s presentation will be available on the Events page, located within the Investors section of Checkpoint’s website, View Source, for approximately 30 days after the meeting.

Lake Street’s 5th Annual Best Ideas Growth Conference:
Date: Wednesday, September 15, 2021
Format: 1×1 meetings only
Mr. Oliviero will be presenting a corporate update at the H.C. Wainwright 23rd Annual Global Investment Conference and will be available for one-on-one meetings during both conferences.